CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company
Chemomab Therapeutics Ltd.
Sign in to watch- Ticker
- CMMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- EIN
- 813676773
- Phone
- 972-77-331-0156
- Business address
- KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
- Former names
- Anchiano Therapeutics Ltd., BioCancell Ltd.
- SCHEDULE 13D Stake Beneficial Ownership Report
- DEFA14A Proxy Proxy Materials
- 6-K Event Report of Foreign Issuer
- EFFECT Other Notice of Effectiveness
- DEFM14A Deal DEFM14A
- S-4/A Deal Registration Statement - Business Combination
- 6-K Event Report of Foreign Issuer
- S-4/A Deal Registration Statement - Business Combination
- 6-K Event Report of Foreign Issuer
- S-4 Deal Registration Statement - Business Combination
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 2,304 shares at an average $2.83 ($6,516)
- 6-K Event Report of Foreign Issuer
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DRS Other Draft Registration Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13D Stake Beneficial Ownership Report
- 6-K Event Report of Foreign Issuer
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
Page 1 of 19 · 368 filings